ResearcherUniversity of Alabama at BirminghamNo recent work listed

Hua Amanda Fang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1669-4898; OpenAlex author ID A5001295276. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 7

Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper

Papers 2

Are Lymph Node Metastases Associated With Survival in Black Patients With Pancreatic Cancer? Co-author DOI 10.1016/j.jss.2022.11.031 ↗
Does race affect the long-term survival benefit of systemic therapy in pancreatic adenocarcinoma? First author DOI 10.1016/j.amjsurg.2022.04.004 ↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Selwyn Maurice Vickers · 2 shared papers, 2022–2023 · strength 0.32
- Paper Are Lymph Node Metastases Associated With Survival in Black Patients With Pancreatic Cancer? DOI 10.1016/j.jss.2022.11.031 ↗
- Paper Does race affect the long-term survival benefit of systemic therapy in pancreatic adenocarcinoma? DOI 10.1016/j.amjsurg.2022.04.004 ↗
Ahmer Irfan · 2 shared papers, 2022–2023 · strength 0.32
- Paper Are Lymph Node Metastases Associated With Survival in Black Patients With Pancreatic Cancer? DOI 10.1016/j.jss.2022.11.031 ↗
- Paper Does race affect the long-term survival benefit of systemic therapy in pancreatic adenocarcinoma? DOI 10.1016/j.amjsurg.2022.04.004 ↗
John Bart Rose · 2 shared papers, 2022–2023 · strength 0.32
- Paper Are Lymph Node Metastases Associated With Survival in Black Patients With Pancreatic Cancer? DOI 10.1016/j.jss.2022.11.031 ↗
- Paper Does race affect the long-term survival benefit of systemic therapy in pancreatic adenocarcinoma? DOI 10.1016/j.amjsurg.2022.04.004 ↗
Olumide B. Gbolahan · 2 shared papers, 2022–2023 · strength 0.32
- Paper Are Lymph Node Metastases Associated With Survival in Black Patients With Pancreatic Cancer? DOI 10.1016/j.jss.2022.11.031 ↗
- Paper Does race affect the long-term survival benefit of systemic therapy in pancreatic adenocarcinoma? DOI 10.1016/j.amjsurg.2022.04.004 ↗
Sushanth Reddy · 2 shared papers, 2022–2023 · strength 0.32
- Paper Are Lymph Node Metastases Associated With Survival in Black Patients With Pancreatic Cancer? DOI 10.1016/j.jss.2022.11.031 ↗
- Paper Does race affect the long-term survival benefit of systemic therapy in pancreatic adenocarcinoma? DOI 10.1016/j.amjsurg.2022.04.004 ↗
Vikas Dudeja · 2 shared papers, 2022–2023 · strength 0.32
- Paper Are Lymph Node Metastases Associated With Survival in Black Patients With Pancreatic Cancer? DOI 10.1016/j.jss.2022.11.031 ↗
- Paper Does race affect the long-term survival benefit of systemic therapy in pancreatic adenocarcinoma? DOI 10.1016/j.amjsurg.2022.04.004 ↗
Seifeldin Awad · 1 shared paper, 2022 · strength 0.15
- Paper Does race affect the long-term survival benefit of systemic therapy in pancreatic adenocarcinoma? DOI 10.1016/j.amjsurg.2022.04.004 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.